As the GLP-1 weight-loss drug market continues to grow, consumers weary of needles now have two options in pill form instead. Eli Lilly, the makers of Zepbound, gained FDA approval for its drug orforglipron, sold under the brand name Foundayo, on April 1, 2026, following Novo Nordisk, which received approval for the Wegovy pill in December 2025. Unlike the injectable forms of the drugs…
If I had to guess, I’d say there are probably 30 to 40 good setups in a day right now....
With rates hovering around 6%-7%, this would shave hundreds of dollars off your monthly mortgage payment and save you a...
Employees work on the production line of automotive display chips at a workshop on May 22, 2026 in Huzhou, Zhejiang...
Residents impacted by the ongoing threat of a hazardous chemical in Orange County, California, may be able to recoup the...
Has gold lost its luster? Traders on both sides of the question are duking it out in the options pit...
Why Carrier is not just a housing-cycle trade Carrier Global (CARR) still gets treated like a simple residential HVAC stock,...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
